DOCSLIB.ORG

Customer Margins for Onechicago Futures

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

#42599 TO: ALL CLEARING MEMBERS DATE: February 9, 2018 SUBJECT: Customer Margins for OneChicago Futures On a monthly basis OCC updates OneChicago scan ranges used in the OCX SPAN parameter file. The new rates become effective on the Tuesday, or second business day, following the standard ‘third Friday of the month’ expiration. The frequency of the updates is intended to keep the customer future’s margin rates more closely aligned with clearing margins, while maintaining regulatory minimums related to security futures. This month’s new rates will be effective on Wednesday 2/21. To receive email notification of these rate changes, which includes an attached file of the rate changes, please subscribe to the ONE Updates list from the OFRA webpage: https://www.theocc.com/risk- management/ofra/ The following scan ranges will be updated and all others will not change: Scan Current Range Commodity Scan Effective Code Name Range 2/21/2018 AA Alcoa Corporation 20.0% 30.2% AABA Altaba Inc. 20.0% 22.9% AAL American Airlines Group Inc. 20.0% 26.4% AAN Aarons Inc 25.8% 37.4% AAP ADVANCED AUTO PARTS INCCOM 36.0% 53.0% AAXN Axon Enterprise, Inc. 25.4% 35.8% AB Alliance Bernstein Holding LP 20.0% 22.1% ABBV Abbvie Inc. 20.8% 22.4% ABC AMERISOURCEBERGEN CORP 20.0% 26.9% ABEV Ambev S.A. ADR 20.0% 22.9% ABMD ABIOMED INCCOM 23.6% 34.4% ABX BARRICK GOLD CORP 27.4% 40.0% ACAD ACADIA PHARMACEUTICALS 35.7% 50.3% ACH ALUMINUM CORP CHINA LTDSPON ADR H SHS 21.8% 31.8% ACHC ACADIA HEALTHCARE COMPANY INCOM 34.0% 50.0% ACIA ACACIA COMMUNICATIONS INCCOM 59.1% 90.4% ACM AECOM 20.0% 27.2% ADBE ADOBE SYS INC 21.6% 31.3% ADS ALLIANCE DATA SYSTEMS CORPCOM 20.0% 30.3% ADSK AUTODESK INC 54.3% 79.3% ADTN ADTRAN INC 20.0% 22.7% AEGN Aegion Corp 24.6% 37.0% AEM Agnico Eagle Mines Limited 22.3% 33.0% AEO AMERICAN EAGLE OUTFITTERS NECOM 24.0% 35.2% AER AERCAP HOLDINGS NVSHS 20.0% 30.1% AFSI AMTRUST FINANCIAL SERVICES ICOM 36.4% 53.1% AGCO AGCO CORP 20.0% 21.2% AGIO AGIOS PHARMACEUTICALS INCCOM 40.5% 59.7% AGM FEDERAL AGRICULTURE CORP CLS C 20.6% 30.7% AGN Allergan plc. 20.0% 23.3% AGX ARGAN INCCOM 20.0% 30.3% AHGP ALLIANCE HOLDINGS GP LPCOM UNITS LP 29.5% 40.5% AHL ASPEN INSURANCE HOLDINGS LTDSHS 20.0% 21.9% AI ARLINGTON ASSET INVT CORPCL A NEW 20.0% 21.6% AINV APOLLO INVT CORPCOM 20.0% 24.4% AIR AAR CORPCOM 20.0% 26.6% AIZ ASSURANT INCCOM 20.0% 23.7% AKAM AKAMAI TECHNOLOGIES INCCOM 24.8% 38.0% AKRX AKORN INCCOM 37.8% 52.6% AKS AK STL HLDG CORP 38.6% 57.1% AL AIR LEASE CORP 20.0% 25.6% ALB ALBEMARLE CORP 20.0% 25.0% ALGN ALIGN TECHNOLOGY INCCOM 20.0% 30.3% ALK ALASKA AIR GROUP INC 20.0% 24.7% ALKS Alkermes plc 41.4% 60.7% ALLY ALLY FINL INCCOM 20.0% 23.7% ALNY ALNYLAM PHARMACEUTICALS INCCOM 55.6% 82.0% ALV AUTOLIV INC 20.0% 27.4% ALXN ALEXION PHARMACEUTICALS INC 21.9% 33.2% AM ANTERO MIDSTREAM PARTNERS LPUNT LTD PARTN 25.9% 37.7% AMAG AMAG Pharmaceuticals Inc 36.0% 52.5% AMAT APPLIED MATERIALS INC 24.2% 35.2% AMBA AMBARELLA INCSHS 30.5% 44.5% AMCX AMC NETWORKS INCCL A 20.0% 23.7% AMD ADVANCED MICRO DEVICES INC 46.4% 69.4% AMED AMEDISYS INCCOM 31.3% 45.8% AMG AFFILIATED MANAGERS GROUP 20.0% 25.3% AMJ JPMORGAN Alerian MLP ETN 20.0% 28.9% AMLP ALPS ETF TRALERIAN MLP 21.4% 31.2% AMN AMN HEALTHCARE SERVICES INCCOM 23.6% 34.4% AMP AMERIPRISE FINL INCCOM 20.0% 23.6% AMTD TD Ameritrade Holding Corp 20.0% 25.5% AMWD AMERICAN WOODMARK CORPCOM 20.0% 28.8% AMX AMERICA MOVIL SAB DE CVSPON ADR L SHS 20.0% 24.3% AMZN AMAZON COM INC 20.0% 25.4% AN AUTONATION INC 20.0% 29.1% ANDV Andeavor 20.0% 26.0% ANDX Andeavor Logistics LP 20.0% 28.1% ANET ARISTA NETWORKS INCCOM 26.0% 38.7% ANF ABERCROMBIE & FITCH CO 36.6% 52.5% ANGI ANGI Homeservices Inc. 59.5% 87.9% ANSS ANSYS, Inc. 20.0% 21.8% AOBC American Outdoor Brands Corporation 30.9% 45.3% APA APACHE CORPCOM 24.0% 37.0% APAM ARTISAN PARTNERS ASSET MGMTCL A 20.0% 22.0% APC ANADARKO PETE CORP 28.0% 41.0% APEI AMERICAN PUBLIC EDUCATION INCOM 38.6% 56.2% APO APOLLO GLOBAL MGMT LLC 20.0% 21.8% APOG APOGEE ENTERPRISES INCCOM 20.0% 30.5% APTV Aptiv PLC 20.0% 28.6% AR ANTERO RES CORPCOM 20.0% 30.5% ARCO ARCOS DORADOS HOLDINGS INC 27.7% 39.8% ARLP ALLIANCE RES PARTNER L P 27.8% 41.0% ARNC Arconic Inc. 22.9% 35.1% ARRS ARRIS International plc 21.0% 31.0% ASB ASSOCIATED BANC CORPCOM 20.0% 21.2% ASTE ASTEC INDS INC 20.0% 28.1% ASX ADVANCED SEMICONDUCTOR ENGRSPONSORED ADR 36.0% 52.5% ATGE Adtalem Global Education Inc. 28.7% 42.2% ATHN ATHENAHEALTH INCCOM 26.8% 39.0% ATI ALLEGHENY TECHNOLOGIES INC 45.1% 66.3% ATVI ACTIVISION BLIZZARD INCCOM 20.0% 30.5% AU ANGLOGOLD ASHANTI LTD 27.6% 40.5% AVGO Broadcom Limited 20.0% 22.7% AVP AVON PRODS INC 40.5% 59.2% AWI ARMSTRONG WORLD INDS INC NEWCOM 20.0% 26.3% AXTA AXALTA COATING SYS LTDCOM 66.9% 98.3% AYI ACUITY BRANDS INCCOM 21.7% 33.0% AZN ASTRAZENECA PLC ADS 20.0% 24.4% AZO AUTOZONE INC 20.0% 24.9% B BARNES GROUP INC 20.0% 21.2% BABA ALIBABA GROUP HLDG LTDSPONSORED ADS 20.0% 24.9% BAC BANK OF AMERICA CORPORATION 20.0% 23.3% BAH BOOZ ALLEN HAMILTON HLDG CORCL A 20.0% 24.9% BAK BRASKEM S ASP ADR PFD A 57.5% 87.6% BB BlackBerry Limited 25.0% 36.5% BBBY BED BATH & BEYOND INC 20.0% 29.6% BBD BANCO BRADESCO S ASP ADR PFD NEW 55.3% 83.8% BBVA BANCO BILBAO VIZCAYA ARGENTINA 20.0% 28.9% BBY BEST BUY INC 23.6% 35.7% BC BRUNSWICK CORP 24.7% 36.0% BCS BARCLAYS PLCADR 26.9% 39.3% BEL Belmond Ltd. 20.0% 23.7% BEN FRANKLIN RES INC 20.0% 21.9% BG BUNGE LIMITEDCOM 22.3% 32.5% BGFV BIG 5 SPORTING GOODS CORPCOM 31.9% 46.9% BGG BRIGGS & STRATTON CORP 21.3% 31.3% BHF BRIGHTHOUSE FINL INCCOM 56.3% 85.4% BHGE Baker Hughes Incorporated 20.0% 30.0% BHP BHP BILLITON LTD 21.8% 31.8% BIDU Baidu Inc 20.0% 24.5% BIG BIG LOTS INCCOM 20.0% 21.6% BIIB Biogen Inc. 20.0% 25.2% BIO BIO RAD LABS INCCL A 20.0% 25.2% BJRI BJs Restaurants Inc. 20.0% 21.4% BKD BROOKDALE SR LIVING INCCOM 30.9% 45.2% BKE BUCKLE INC 24.4% 35.9% BKEP BLUEKNIGHT ENERGY PARTNERS LCOM UNIT 20.0% 27.9% BKI BLACK KNIGHT INCCOM 58.6% 90.2% BKS BARNES & NOBLES INC 41.2% 60.7% BKU BANKUNITED INCCOM 20.0% 23.2% BLMN Bloomin Brands Inc. 20.0% 29.4% BLUE BLUEBIRD BIO INCCOM 38.6% 56.9% BMRN BIOMARIN PHARMACEUTICAL INC 21.6% 31.6% BMY BRISTOL MYERS SQUIBB CO 20.0% 25.7% BOFI BOFI HLDG INCCOM 27.1% 39.6% BOKF BOK FINL CORPCOM NEW 20.0% 21.3% BOTZ GLOBAL X ROBOTICS & ARTIFICI 63.1% 93.7% BPI BRIDGEPOINT ED INCCOM 32.4% 49.1% BPL BUCKEYE PARTNERS L P 20.0% 23.9% BPOP POPULAR INC 20.0% 25.7% BRF VanEck Vectors Brazil Small-Cap ETF 20.0% 25.0% BRFS BRF S.A. 20.0% 28.7% BRKR BRUKER CORPCOM 20.0% 22.6% BRX BRIXMOR PPTY GROUP INCCOM 20.0% 26.7% BSAC BANCO SANTANDER CHILE NEWSP ADR REP COM 20.0% 21.7% BSBR BANCO SANTANDER BRASIL S AADS REP 1 UNIT 23.2% 35.3% BSX BOSTON SCIENTIFIC CORP 20.0% 28.8% BURL BURLINGTON STORES INCCOM 20.0% 27.5% BVN COMPANIA DE MINAS BUENAVENTUSPONSORED ADR 29.0% 42.1% BWA BORGWARNER INCCOM 20.0% 26.3% BWLD BUFFALO WILD WINGS INC 26.3% 38.5% BWP BOARDWALK PIPELINE PARTNERSUT LTD PARTNER 20.0% 24.9% BX BLACKSTONE GROUP L PCOM UNIT LTD 20.0% 22.9% BXS BancorpSouth Bank 20.0% 23.2% BYD BOYD GAMING CORP 20.0% 26.3% BZH BEAZER HOMES USA INC 31.0% 45.3% C CITIGROUP INC 20.0% 25.7% CA CA, Inc. 20.0% 21.1% CAA CalAtlantic Group, Inc. 20.0% 25.6% CACC CREDIT ACCEP CORP MICHCOM 21.3% 31.1% CAH CARDINAL HEALTH INC 20.0% 25.6% CAKE CHEESECAKE FACTORY INCCOM 20.0% 24.8% CALL magicJack VocalTec Ltd 34.0% 49.7% CAR Avis Budget Group Inc 34.1% 50.1% CARA CARA THERAPEUTICS INCCOM 64.2% 95.3% CAVM Cavium, Inc. 23.8% 34.7% CBD Companhia Brasileira de Distribuicao 57.9% 87.9% CBG CBRE Group Inc. 20.0% 24.3% CBI CHICAGO BRIDGE & IRON CO N VN Y REGISTRY SH 38.7% 56.8% CBL CBL & ASSOC PPTYS INCCOM 25.9% 38.0% CBRL Cracker Barrel Old Country Store 20.0% 21.4% CCC CALGON CARBON CORPCOM 32.0% 46.8% CCE Coca Cola European Partners plc 58.2% 88.5% CCJ CAMECO CORP 25.4% 37.2% CCO CLEAR CHANNEL OUTDOOR HLDGSCL A 28.7% 44.1% CDE Coeur Mining Inc.
Recommended publications
  • In Re Urban Outfitters, Inc. Securities Litigation 13-CV-05978-Amended

    In Re Urban Outfitters, Inc. Securities Litigation 13-CV-05978-Amended

    Case 2:13-cv-05978-LFR Document 11 Filed 03/10/14 Page 1 of 86 IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA In ie. Urban Outfitters, Inc. Master File Securities Litigation No 2 l3-c' 05978-1 FR This Document Relates To: All Actions, AMENDED CLASS ACTION COMPLAINT FOR VIOLATIONS OF THE FEDERAL SECURITIES LAWS Case 2:13-cv-05978-LFR Document 11 Filed 03/10/14 Page 2 of 86 rFAJ311 OF CONTENTS Page 1. SUMMARY OF THE ACTION .......................................................................................... H. JURISDICTION AND VENUE .......................................................................................... 5 111. PARTIES ............................................................................................................................. A. Plaintiff.................................................................................................................... B, Defendants ...............................................................................................................6 IV. SUBSTANTIVE ALLEGATIONS ...................................................................................10 A. Confidential Witnesses .......................................................................................... Jo B. Background of the Company and Its Brands .........................................................12 C. 'Comparable" Sales Growth Is a Key Metric in the Retail Industry..................... 15 I), Leading Up to the Class Period, the Urban Outfitters Brand Achieved
  • 2021 Sustainability and Annual Report FINANCIAL HIGHLIGHTS

    2021 Sustainability and Annual Report FINANCIAL HIGHLIGHTS

    Ready TRIUMPH GROUP 2021 Sustainability and Annual Report FINANCIAL HIGHLIGHTS (in millions, except per share data) TOTAL BACKLOG Fiscal Year Ended March 31 2021 2020 2019 $ in billions $ 1,870 Net sales $ 2,900 $ 3,365 $ Ready to fly Adjusted operating income 108 218 166 ( ) Adjusted net income 2 137 115 Adjusted diluted earnings per share $ (0.03) $ 2.69 $ 2.38 ( ) Cash flow from operations 173 97 (174) Total assets $ 2,451 $ 2,980 $ 2,855 Total debt 1,958 1,808 1,489 Total equity (819) (781) (573) AFTER ONE OF THE TOUGHEST YEARS OUR INDUSTRY HAS EVER NON-GAAP RECONCILIATION FACED, IT IS ENCOURAGING TO HAVE AN ABUNDANCE OF GOOD Operating (loss) income – GAAP $ (326) $ 58 $ (275) Loss on sale of assets & businesses 105 57 235 NEWS. TRIUMPH GROUP HAS EMERGED FROM FIVE YEARS OF Forward losses — — 87 SALES BY END MARKET ARDUOUS RESTRUCTURING AS A MUCH STRONGER AND MORE Restructuring 53 25 31 Legal judgment gain, net — (9) — Regional Jet .% .% Non-Aviation AGILE COMPANY. OUR MARKETS ARE POISED FOR GROWTH, AND Impairments 276 66 — Business Jet Other — 21 87 % Adjusted operating income* 108 218 166 WE ARE POSITIONED FAVORABLY AND SUSTAINABLY WITHIN Interest & other (171) (122) (115) % THEM. OUR PEOPLE ARE SUPPORTED AND FOCUSED. OUR Non-service defined benefit income 50 41 57 % 15 Less: Financing charges 3 1 Military Adjusted income before income taxes* 1 140 110 Commercial PROFITABILITY IS IMPROVING. UP IS WHERE WE ARE GOING. (3) Income taxes (6) 5 DECISIVELY, DECIDEDLY UP. Tax effect of adjustments — 3 — Adjusted net income (2) 137 115 ADJUSTED SEGMENT OPERATING INCOME Diluted earnings per share – GAAP $ (8.55) $ (0.58) $ (6.58) Per share impact of adjustments 8.52 3.27 8.96 ( ) Aerospace Adjusted diluted earnings per share $ 0.03 $ 2.69 $ 2.38 Structures Weighted average diluted shares 53.0 52.0 49.7 % *Differences due to rounding ABOUT TRIUMPH % Triumph Group, Inc.
  • VANGUARD SCOTTSDALE FUNDS Form NPORT-P Filed 2021-07-30

    VANGUARD SCOTTSDALE FUNDS Form NPORT-P Filed 2021-07-30

    SECURITIES AND EXCHANGE COMMISSION FORM NPORT-P Filing Date: 2021-07-30 | Period of Report: 2021-05-31 SEC Accession No. 0001752724-21-162153 (HTML Version on secdatabase.com) FILER VANGUARD SCOTTSDALE FUNDS Mailing Address Business Address PO BOX 2600 PO BOX 2600 CIK:1021882| IRS No.: 232439140 | State of Incorp.:DE | Fiscal Year End: 0831 V26 V26 Type: NPORT-P | Act: 40 | File No.: 811-07803 | Film No.: 211131481 VALLEY FORGE PA 19482 VALLEY FORGE PA 19482 6106691000 Copyright © 2021 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document Vanguard® Russell 2000 Value Index Fund Schedule of Investments (unaudited) As of May 31, 2021 The fund files its complete schedule of portfolio holdings with the Securities and Exchange Commission (SEC) for the first and third quarters of each fiscal year as an exhibit to its reports on Form N-PORT. The fund’s Form N-PORT reports are available on the SEC’s website at www.sec.gov. Market Value Shares ($000) Common Stocks (99.8%) Basic Materials (6.1%) * Cleveland-Cliffs Inc. 377,967 7,605 * Alcoa Corp. 157,673 6,255 U.S. Steel Corp. 219,606 5,694 Avient Corp. 76,914 3,998 Hecla Mining Co. 439,325 3,954 Commercial Metals Co. 100,099 3,150 * Arconic Corp. 83,775 3,030 * Domtar Corp. 46,252 2,508 Minerals Technologies Inc. 28,676 2,495 * Livent Corp. 123,488 2,409 Stepan Co. 16,682 2,246 Mueller Industries Inc. 47,072 2,186 * Coeur Mining Inc. 203,839 2,120 Worthington Industries Inc.
  • NASDAQ Stock Market

    NASDAQ Stock Market

    Nasdaq Stock Market Friday, December 28, 2018 Name Symbol Close 1st Constitution Bancorp FCCY 19.75 1st Source SRCE 40.25 2U TWOU 48.31 21st Century Fox Cl A FOXA 47.97 21st Century Fox Cl B FOX 47.62 21Vianet Group ADR VNET 8.63 51job ADR JOBS 61.7 111 ADR YI 6.05 360 Finance ADR QFIN 15.74 1347 Property Insurance Holdings PIH 4.05 1-800-FLOWERS.COM Cl A FLWS 11.92 AAON AAON 34.85 Abiomed ABMD 318.17 Acacia Communications ACIA 37.69 Acacia Research - Acacia ACTG 3 Technologies Acadia Healthcare ACHC 25.56 ACADIA Pharmaceuticals ACAD 15.65 Acceleron Pharma XLRN 44.13 Access National ANCX 21.31 Accuray ARAY 3.45 AcelRx Pharmaceuticals ACRX 2.34 Aceto ACET 0.82 Achaogen AKAO 1.31 Achillion Pharmaceuticals ACHN 1.48 AC Immune ACIU 9.78 ACI Worldwide ACIW 27.25 Aclaris Therapeutics ACRS 7.31 ACM Research Cl A ACMR 10.47 Acorda Therapeutics ACOR 14.98 Activision Blizzard ATVI 46.8 Adamas Pharmaceuticals ADMS 8.45 Adaptimmune Therapeutics ADR ADAP 5.15 Addus HomeCare ADUS 67.27 ADDvantage Technologies Group AEY 1.43 Adobe ADBE 223.13 Adtran ADTN 10.82 Aduro Biotech ADRO 2.65 Advanced Emissions Solutions ADES 10.07 Advanced Energy Industries AEIS 42.71 Advanced Micro Devices AMD 17.82 Advaxis ADXS 0.19 Adverum Biotechnologies ADVM 3.2 Aegion AEGN 16.24 Aeglea BioTherapeutics AGLE 7.67 Aemetis AMTX 0.57 Aerie Pharmaceuticals AERI 35.52 AeroVironment AVAV 67.57 Aevi Genomic Medicine GNMX 0.67 Affimed AFMD 3.11 Agile Therapeutics AGRX 0.61 Agilysys AGYS 14.59 Agios Pharmaceuticals AGIO 45.3 AGNC Investment AGNC 17.73 AgroFresh Solutions AGFS 3.85
  • West Palm Beach Firefighters' Pension Fund, Et Al. V. Conagra

    West Palm Beach Firefighters' Pension Fund, Et Al. V. Conagra

    Case: 1:19-cv-01323 Document #: 123 Filed: 10/15/20 Page 1 of 53 PageID #:1849 UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION WEST PALM BEACH FIREFIGHTERS’ PENSION FUND, Plaintiff, Case No. 19-cv-01323 v. Judge Martha M. Pacold CONAGRA BRANDS, INC. et al., Defendants. MEMORANDUM OPINION AND ORDER In 2018, Conagra Brands, Inc. acquired Pinnacle Foods. To fund the merger, Conagra held a secondary public offering (“SPO”). After the merger was complete, Conagra reported disappointing financial results and Conagra’s stock fell. Plaintiffs National Elevator Industry Pension Fund, City of Taylor Police and Fire Retirement System, and City of Sarasota Police Officers’ Pension Plan sued Defendants Conagra, Sean Connolly (Conagra’s CEO), David Marberger (Conagra’s CFO), a slate of Conagra directors, and the underwriters to the SPO, alleging violations of the Securities Act of 1933 (the “Securities Act”) and the Securities Exchange Act of 1934 (the “Exchange Act”). Defendants move to dismiss. [75]. For the reasons below, the motion is granted. Background For purposes of Defendants’ motion to dismiss, the court accepts as true the well-pleaded factual allegations of the consolidated class action complaint and draws all reasonable inferences in Plaintiffs’ favor. Tamayo v. Blagojevich, 526 F.3d 1074, 1081 (7th Cir. 2008). The court also considers the documents attached to the complaint, documents that are critical to the complaint and referred to in it, information that is subject to proper judicial notice, and additional facts set forth in Plaintiffs’ opposition to the motion to dismiss, to the extent those facts are consistent with the pleadings.
  • Healthcare Transactions: Year in Review

    Healthcare Transactions: Year in Review

    HEALTHCARE TRANSACTIONS: YEAR IN REVIEW JANUARY 2019 bassberry.com OVERVIEW 2018 marked a year of continued robust healthcare merger and acquisition activity, with deal volume surpassing that of 2017. The dollar volume of healthcare deals also exceeded 2017, highlighted by CVS Health Corp. (NYSE: CVS) surviving regulatory scrutiny and finalizing its purchase of Aetna for $69 billion, and Cigna (NYSE: CI) closing its $67 billion merger with pharmacy benefit manager Express Scripts (Nasdaq: ESRX). Private equity firm KKR & Co. Inc. (NYSE: KKR) acquired Envision Healthcare Corporation (NYSE: EVHC) in a going private transaction for $9.9 billion; and in November, LifePoint Health, Inc. (Nasdaq: LPNT) merged with Apollo Global Management-owned RCCH HealthCare Partners for an estimated $5.6 billion. Not only do these deals show the energy of the industry, but they also represent a seismic shift in healthcare. Cross-sector transactions, such as the CVS-Aetna and Cigna-Express Scripts transactions, are becoming more frequent and disrupt traditional industry models. By seeking alliances across industry lines, healthcare companies aim both to reduce costs and improve care coordination as well as realign incentives to better meet consumer demands. As providers fight to stay profitable in the wake of value-based reimbursement, these cross-sector combinations may foreshadow the future of the healthcare industry. Many of these same drivers also have led to increasing private equity investment in the industry. The need for innovation and disruption via consolidation adds further appeal to investors. The injection of capital by private equity firms allows healthcare providers to cut costs and increase efficiencies, and the shift in reimbursement presents a unique opportunity for firms to help providers and systems reposition.
  • URBAN OUTFITTERS, INC. (Exact Name of Registrant As Specified in Its Charter)

    URBAN OUTFITTERS, INC. (Exact Name of Registrant As Specified in Its Charter)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File No. 000-22754 URBAN OUTFITTERS, INC. (Exact Name of Registrant as Specified in Its Charter) Pennsylvania 23-2003332 (State or Other Jurisdiction of (I.R.S. Employer Incorporation or Organization) Identification No.) 5000 South Broad Street, Philadelphia, PA 19112-1495 (Address of Principal Executive Offices) (Zip Code) Registrant’s telephone number, including area code: (215) 454-5500 Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Shares, par value $.0001 per share URBN NASDAQ Global Select Market Securities registered pursuant to Section 12(g) of the Act: None Indicate by checkmark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐ Indicate by checkmark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒ Indicate by checkmark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
  • Texas Ethics Commission 2020 Lobbyist with Clients Ordered by Lobbyist Name Printed on Oct 2, 2021 Key for Compensation Amount Codes

    Texas Ethics Commission 2020 Lobbyist with Clients Ordered by Lobbyist Name Printed on Oct 2, 2021 Key for Compensation Amount Codes

    Texas Ethics Commission 2020 Lobbyist With Clients Ordered By Lobbyist Name Printed On Oct 2, 2021 Key for Compensation Amount Codes LOBBCOMPEQZERO $0 LOBBCOMP05 $100,000 - $149,999.99 LOBBCOMP10 $350,000 - $399,999.99 LOBBCOMP01 Less than $10,000 LOBBCOMP06 $150,000 - $199, 999.99 LOBBCOMP11 $400,000 - $449,999.99 LOBBCOMP02 $10,000 - $24,999.99 LOBBCOMP07 $200,000 - $249, 999.99 LOBBCOMP12 $450,000 - $499,999.99 LOBBCOMP03 $25,000 - $49,000.99 LOBBCOMP08 $250,000 - $299,999.99 LOBBCOMP13 Over $500,000 LOBBCOMP04 $50,000 - $99,999.99 LOBBCOMP09 $300,000 - $349,999.99 LOBBCOMPEXACTAMT 70358 #1 Abbott, Sean (Mr.) Attorney 100 Congress Avenue Suite 1300 Austin TX (512)4352334 MODIFIED 3 B&J Municipal Utility District c/o Armbrust & Brown, PLLC 100 Congress Austin TX 78701 LOBBCOMP01 PAID 01/01/2020 to12/31/2020 Avenue, Suite 1300 Bell County Municipal Utility District No. 1 c/o Armbrust & Brown, PLLC 100 Congress Austin TX 78701 LOBBCOMP01 PAID 01/01/2020 to12/31/2020 Avenue, Suite 1300 Bell County Municipal Utility District No. 2 c/o Armbrust & Brown, PLLC 100 Congress Austin TX 78701 LOBBCOMP01 PAID 01/01/2020 to12/31/2020 Avenue, Suite 1300 Berry Creek Highlands Municipal Utility District c/o Armbrust & Brown, PLLC 100 Congress Austin TX 78701 LOBBCOMP01 PAID 01/01/2020 to12/31/2020 Avenue, Suite 1300 Blake Magee Company 1011 North Lamar Austin TX 78704 LOBBCOMP01 PAID 01/01/2020 to12/31/2020 Block House Municipal Utility District c/o Armbrust & Brown, PLLC 100 Congress Austin TX 78701 LOBBCOMP01 PAID 01/01/2020 to12/31/2020 Avenue, Suite 1300 Bonzo, LP 3939 Bee Caves Rd.
  • Private Equity Buyouts in Healthcare: Who Wins, Who Loses? Eileen Appelbaum and Rosemary Batt Working Paper No

    Private Equity Buyouts in Healthcare: Who Wins, Who Loses? Eileen Appelbaum and Rosemary Batt Working Paper No

    Private Equity Buyouts in Healthcare: Who Wins, Who Loses? Eileen Appelbaum* and Rosemary Batt† Working Paper No. 118 March 15, 2020 ABSTRACT Private equity firms have become major players in the healthcare industry. How has this happened and what are the results? What is private equity’s ‘value proposition’ to the industry and to the American people -- at a time when healthcare is under constant pressure to cut costs and prices? How can PE firms use their classic leveraged buyout model to ‘save healthcare’ while delivering ‘outsized returns’ to investors? In this paper, we bring together a wide range of sources and empirical evidence to answer these questions. Given the complexity of the sector, we focus on four segments where private equity firms have been particularly active: hospitals, outpatient care (urgent care and ambulatory surgery centers), physician staffing and emergency * Co-Director and Senior Economist, Center for Economic and Policy Research. [email protected] † Alice H. Cook Professor of Women and Work, HR Studies and Intl. & Comparative Labor ILR School, Cornell University. [email protected]. We thank Andrea Beaty, Aimee La France, and Kellie Franzblau for able research assistance. room services (surprise medical billing), and revenue cycle management (medical debt collecting). In each of these segments, private equity has taken the lead in consolidating small providers, loading them with debt, and rolling them up into large powerhouses with substantial market power before exiting with handsome returns. https://doi.org/10.36687/inetwp118 JEL Codes: I11 G23 G34 Keywords: Private Equity, Leveraged Buyouts, health care industry, financial engineering, surprise medical billing revenue cycle management, urgent care, ambulatory care.
  • Investor Overview February 2020 Forward Looking Statements

    Investor Overview February 2020 Forward Looking Statements

    Investor Overview February 2020 Forward Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are often, but not always, identified by the use of words such as “anticipate”, “believe”, “expect”, “plan”, “intend”, “project”, “may”, “will”, “should”, “could”, or similar words suggesting future outcomes or outlooks. These forward-looking statements include, but are not limited to, statements of expectations of or assumptions about strategic actions, objectives, expectations, intentions, aerospace market conditions, aircraft production rates, financial and operational performance, revenue and earnings growth and profitability and earnings results. These statements are based on the current projections, expectations and beliefs of Triumph’s management. These forward looking statements involve known and unknown risks, uncertainties and other factors which could cause actual results to differ materially from any expected future results, performance or achievements, including, but not limited to, competitive and cyclical factors relating to the aerospace industry, dependence on some of Triumph’s business from key customers, requirements of capital, uncertainties relating to the integration of acquired businesses, general economic conditions affecting Triumph’s business segments, product liabilities in excess of insurance, technological developments, limited availability of raw materials or skilled personnel, changes in governmental regulation and oversight and international hostilities and terrorism. Further information regarding the important factors that could cause actual results, performance or achievements to differ from those expressed in any forward looking statements can be found in Triumph’s reports filed with the SEC, including in the risk factors described in Triumph’s Annual Report on Form 10-K for the fiscal year ended March 31, 2019.
  • Supplier Attendance List

    Supplier Attendance List

    2004 Global Supplier Conference Supplier Attendance List Last Name First Name Company City State Country Sopp Robert AAR Garden City NY USA Jones Alan Able Engineering Inc. Goleta CA USA Henderson Mark Accra Manufacturing Inc Bothell WA USA Lyon Daniela Accra Manufacturing Inc Bothell WA USA Mehus Keith Accra Manufacturing Inc Bothell WA USA Farr Keith Advanced Optical Systems Huntsville AL USA Nelson Kimberly Advanced Optical Systems Huntsville AL USA Magpayo Michael Aerojet General Corp. Aerospace Industries Association Of America, Lewandowski William Inc. Arlington VA USA Feutz John AIM Aviation Auburn Inc Auburn WA USA Larson John AIM Aviation Auburn Inc Auburn WA USA Hendricksen John Air Cruisers Company Inc. Wall Township NJ USA Redento Jose Air Cruisers Company Inc. Wall Township NJ USA Belnoski Lawrence Air Products And Chemicals, Inc. Allentown PA USA McNallen John Air Products And Chemicals, Inc. Allentown PA USA Meyer James Airgas Radnor PA USA Whinfrey Thomas Aitech Chatsworth CA USA Clelland Jim Alcoa Engineered Products Lafayette IN USA Vandedrinck Caroline Alcoa Wheel And Forged Products Cleveland OH USA Thomas Paul Alcoa Chicago IL USA Kiskaddon Harry Alcoa Zappa Giorgio Alenia Aeronautica Rome Italy Assereto Roberto Alenia Aeronautica Spa Torino Italy Braccini Sergio Alenia Aeronautica Spa Pomigliano d'Arco (NA) Italy Caruso Guglielmo Alenia Aeronautica Spa Pomigliano d'Arco Italy Giuseppe Giordo Alenia Aeronautica SPA Caiazzo Vincenzo Alenia Inc. Washington, DC USA McGee Charles All Points Logistics Inc Gainesville GA USA Monkress Phillip All Points Logistics Inc Gainesville GA USA Beard Eric AMI Metals, Inc Brentwood TN USA Cole Cecil Applied Industrial Technologies Cleveland OH USA Geddes Norman Applied Systems Intelligence Inc.
  • About Finch Brands

    About Finch Brands

    ® about finch brands ABOUT US finch brands is a real-world branding agency. Like the finches whose beaks inspired Darwin’s theory of evolution, brands that adapt to the ever-changing environment not only survive, they thrive. We draw our name and inspiration from the forces that shape the natural world to help our clients succeed in the real world. Finch Brands was founded in 1998 by executives instrumental in the ascent of IKEA and David’s Bridal. Their original vision was to create the firm they were never able to find when they were in our clients’ shoes – an end-to-end brand development and management powerhouse that seamlessly delivers breakthrough brand strategy and irrepressibly creative brand design. To accomplish this, we have brought together a team of leaders from brand- first organizations like Campbell Soup Company, NPR, and Urban Outfitters. These experiences make us a better, more instinctive partner – and we put this hard-earned experience to work for clients across categories and all along the growth track. SERVICES our goal is to be the most consequential partner with whom our clients will ever engage. BRAND DEVELOPMENT BRAND MANAGEMENT vision and mission strategic counsel and growth planning brand strategy brand tracking and brand health brand architecture product/service innovation funnel identity (naming, logo, tagline) pricing brand standards/design systems brand extension / elasticity packaging design and POP advertising campaign development and launch internal brand rollout / training marketing planning / demand generation launch planning and execution social media strategy / program management web design and digital strategy MARKET RESEARCH quantitative surveys focus groups in-depth interviews (IDI) ethnography digital bulletin boards virtual communities in-home research store visits and mystery shopping custom methodologies EXECUTIVE TEAM EXECUTIVE DANIEL ERLBAUM CEO A retailer and business builder, Daniel co-founded Finch Brands after serving as an original investor and Vice President at David’s Bridal.